Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
SOAs
SOAs
18/02/2020
Statement of Advice (SOA): tadalafil (Adcirca) 296
18/02/2020
Statement of Advice (SOA): tadalafil (Cialis) 618
18/02/2020
Statement of Advice (SOA): capsaicin (Qutenza) 2889
18/02/2020
Statement of Advice (SOA): collagenase Clostridium histolyticum (Xiapex) 912
18/02/2020
Statement of Advice (SOA): conjugated oestrogens bazedoxifene (Duavive) 1511
18/02/2020
Statement of Advice (SOA): crizotinib (Xalkori) 3207
18/02/2020
Statement of Advice (SOA): dapoxetine (Priligy) 1671
18/02/2020
Statement of Advice (SOA): daptomycin (Cubicin) 3721
18/02/2020
Statement of Advice (SOA): daptomycin (Cubicin) 2935
18/02/2020
Statement of Advice (SOA): strontiumranelate (Protelos) 1413
18/02/2020
Statement of Advice (SOA): sonidegib (Odomzo) 2617
18/02/2020
Statement of Advice (SOA): somatropin (SomatropinBiopartners) 2256
18/02/2020
Statement of Advice (SOA): sodium oxybate (Xyrem) 279
18/02/2020
Statement of Advice (SOA): Sirolimus (Rapamune) 2707
18/02/2020
Statement of Advice (SOA): Daratumumab (Darzalex ) 2821
18/02/2020
Statement of Advice (SOA): darunavir (Prezista) 2580
18/02/2020
Statement of Advice (SOA): decitabine (Dacogen) 507
18/02/2020
Statement of Advice (SOA): deferasirox (Exjade) 1621
18/02/2020
Statement of Advice (SOA): delamanid (Deltyba) 1828
18/02/2020
Statement of Advice (SOA): denosumab (Xgeva) 1351
1
2
3
4
5
6
7
8
9
10
11
Follow AWTTC: